Rodent models of congenital cytomegalovirus infection

Methods in Molecular Biology

Volumn 1119, Issue , 2014, Pages 289-310

  Cekinovic, Djurdjica ^a   Lisnic, Vanda Juranic ^a   Jonjic, Stipan ^a  

^a NONE

Author keywords

Brain; Congenital infections; Cytomegalovirus

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CXCL3 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 7; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

ADAPTIVE IMMUNITY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; BRAIN TISSUE; CELL INFILTRATION; CELL ISOLATION; CEREBELLUM; CLINICAL ASSESSMENT; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEVELOPMENTAL DISORDER; ENCEPHALITIS; FEMALE; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; MOLECULAR BIOLOGY; MONONUCLEAR CELL; MOTOR DYSFUNCTION; MOUSE; MURINE CYTOMEGALOVIRUS; NEWBORN; NONHUMAN; PATHOGENESIS; PERINATAL INFECTION; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RODENT MODEL; SENSORY DYSFUNCTION; SPECIES DIFFERENCE; VERTICAL TRANSMISSION; VIREMIA; VIRUS REPLICATION; ANIMAL; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; METHODOLOGY; MUROMEGALOVIRUS; PATHOGENICITY; PATHOLOGY; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MOLECULAR BIOLOGY; MUROMEGALOVIRUS;

EID: 84907917549     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-788-4_16     Document Type: Article

References (37)

1. Britt W (2010) Cytomegalovirus. In: Remington JS et al (eds) Infectious diseases of the fetus and newborn infant. Elsevier, Philadelphia, pp 706–756
2. Cannon MJ (2009) Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 46(Suppl 4):S6–S10
3. Becroft DMO (1981) Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis. In: Rosenberg HS, Bernstein J (eds) Perspective in pediatric pathology. Masson, New York, pp 203–241
4. Morton CC, Nance WE (2006) Newborn hearing screening – a silent revolution. N Engl J Med 354(20):2151–2164
5. Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17(4):253–276
6. Ross SA, Boppana SB (2005) Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis 16(1):44–49
7. Cheeran MC, Lokensgard JR, Schleiss MR (2009) Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 22(1):99–126, Table of Contents
8. Griffith BP, Lucia HL, Hsiung GD (1982) Brain and visceral involvement during congenital cytomegalovirus infection of guinea pigs. Pediatr Res 16(6):455–459
9. Keithley EM, Woolf NK, Harris JP (1989) Development of morphological and physiological changes in the cochlea induced by cytomegalovirus. Laryngoscope 99(4):409–414
10. Streblow DN et al (2008) Mechanisms of cytomegalovirus- accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 325:397–415
11. Priscott PK, Tyrrell DA (1982) The isolation and partial characterisation of a cytomegalovirus from the brown rat, Rattus norvegicus. Arch Virol 73(2):145–160
12. Loh HS et al (2003) Characterization of a novel rat cytomegalovirus (RCMV) infecting placenta-uterus of Rattus rattus diardii. Arch Virol 148(12):2353–2367
13. Loh HS et al (2006) Pathogenesis and vertical transmission of a transplacental rat cytomegalovirus. Virol J 3:42
14. Li L et al (2008) Induction of cytomegalovirusinfected labyrinthitis in newborn mice by lipopolysaccharide: a model for hearing loss in congenital CMV infection. Lab Invest 88(7):722–730
15. Ishiwata M et al (2006) Differential expression of the immediate-early 2 and 3 proteins in developing mouse brains infected with murine cytomegalovirus. Arch Virol 151(11):2181–2196
16. Tsutsui Y (2009) Effects of cytomegalovirus infection on embryogenesis and brain development. Congenit Anom (Kyoto) 49(2):47–55
17. Koontz T et al (2008) Altered development of the brain after focal herpesvirus infection of the central nervous system. J Exp Med 205(2): 423–435
18. Wu CA et al (2011) Transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonates. J Virol 85(10): 5115–5124
19. Kosugi I et al (2002) Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons. Am J Pathol 161(3):919–928
20. van Den Pol AN et al (1999) Cytomegalovirus cell tropism, replication, and gene transfer in brain. J Neurosci 19(24):10948–10965
21. Stagno S, Britt WJ (2006) Cytomegalovirus. In: Remington JS, Klein JO (eds) Diseases of the fetus and newborn infant. Saunders, Philadelphia, PA
22. de Vries LS et al (2004) The spectrum of cranial ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection. Neuropediatrics 35(2):113–119
23. Trgovcich J et al (1998) Pathogenesis of murine cytomegalovirus infection in neonatal mice. In: Scholz M et al (eds) CMV-related immunopathology monographs in virology. Karger, Basel, Switzerland
24. Slavuljica I et al (2010) Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest 120(12):4532–4545
25. Bantug GR et al (2008) CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals. J Immunol 181(3):2111–2123
26. Holtappels R et al (2000) Enrichment of immediate-early 1 (m123/pp 89) peptidespecific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 74(24):11495–11503
27. Podlech J et al (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74(16):7496–7507
28. Jonjic S et al (1994) Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179(5):1713–1717
29. Polic B et al (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188(6):1047–1054
30. Fowler KB et al (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326(10):663–667
31. Adler SP et al (1995) Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 171(1):26–32
32. Ross SA et al (2011) Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis 204(7):1003–1007
33. Boppana SB et al (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344(18):1366–1371
34. Cekinovic D et al (2008) Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. J Virol 82(24): 12172–12180
35. Becroft DM (1981) Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis. Perspect Pediatr Pathol 6:203–241
36. Wirtz N et al (2008) Polyclonal cytomegalovirusspecific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues. Med Microbiol Immunol 197(2):151–158
37. Harris JP et al (1984) Immunologic and electrophysiological response to cytomegaloviral inner ear infection in the guinea pig. J Infect Dis 150(4):523–530